{
  "trial_id": "NCT00294775",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Symptomatic severe AVS referred for valve replacement",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Signed informed consent",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "Severe renal failure (s-creatinine >300 mmole/l)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Moderate or severe hepatic failure",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Moderate or severe LV systolic dysfunction (LVEF<40%)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients already treated with ACE-I or ARB",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known intolerance for ARB",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Unwilling to participate in the study",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has severe aortic stenosis and is referred for valve replacement.",
  "_meta": {
    "topic_id": "2",
    "trial_id": "NCT00294775",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}